Amanote Research

Amanote Research

    RegisterSign In

Tumor-Agnostic Therapy Gets on TRK

Science - United States
doi 10.1126/science.360.6384.45-d
Full Text
Open PDF
Abstract

Available in full text

Categories
MultidisciplinaryPhilosophy of ScienceHistory
Date

April 5, 2018

Authors
Paula A. Kiberstis
Publisher

American Association for the Advancement of Science (AAAS)


Related search

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy

Targeted Oncology
Cancer ResearchOncologyPharmacology
2018English

Ulcer Therapy Gets Thumbs Up

Vital
2005English

Agnostic About Agriculture

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Occupational Therapy Gets Stroke Patients Out of the House

British Medical Journal
Medicine
2004English

Discovery of GNF-5837, a Selective TRK Inhibitor With Efficacy in Rodent Cancer Tumor Models

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2012English

Selective TRK Inhibitor CH7057288 Against TRK Fusion-Driven Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Toward Efficient Agnostic Learning

1992English

Classifier-Agnostic Saliency Map Extraction

Proceedings of the AAAI Conference on Artificial Intelligence
2019English

Obesity Gets on Your Renal Nerves

Acta Physiologica
Physiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy